Time trends in breast cancer and menopause hormone therapy use in New Zealand
Authors:
- 17 November 2015
- journal article
- research article
- Published by Taylor & Francis in Climacteric
- Vol. 19 (1) , 42-48
Abstract
Objective The publication of preliminary findings from the Women’s Health Initiative (WHI) Study in 2002 suggested an increased risk of breast cancer among users of menopause hormone therapy (MHT). This resulted world-wide in a rapid and significant decline in the use of hormone therapy. It was later claimed that breast cancer incidence rates had fallen as a result of lower rates of hormone therapy use. Our aim was to investigate whether there was an association between changes in the use of hormone therapy and rates of breast cancer diagnosis in New Zealand subsequent to the publication of the WHI. Method Validated prescription usage data along with breast cancer screening and cancer registration data were accessed. Time trends extending for 8 years after the publication of the WHI were assessed. Results The use of hormone therapy for managing menopausal symptoms fell by about 70% following the controversy about its safety. Breast cancer registration rates among women aged 50–59 years had started to fall in advance of this change in prescribing. Changes in other age groups appear to coincide with changes in the screening eligibility for the national breast screening program rather than use of hormone therapy. Conclusion The time trend analysis does not support an association between changes in hormone therapy use and the incidence rate of breast cancer.Keywords
This publication has 11 references indexed in Scilit:
- Hormone therapy for preventing cardiovascular disease in post-menopausal womenCochrane Database of Systematic Reviews, 2015
- Recent Changes in Breast Cancer Incidence in Spain, 1980–2004JNCI: Journal of the National Cancer Institute, 2009
- HRT and Breast Cancer: Recent Findings in the Context of the Evidence to DateWomen's Health, 2008
- Declining breast cancer incidence and decreased HRT useThe Lancet, 2008
- Re: Declines in Invasive Breast Cancer and Use of Postmenopausal Hormone Therapy in a Screening Mammography PopulationJNCI: Journal of the National Cancer Institute, 2008
- Breast Cancer Incidence, 1980 2006: Combined Roles of Menopausal Hormone Therapy, Screening Mammography, and Estrogen Receptor StatusJNCI: Journal of the National Cancer Institute, 2007
- The Decrease in Breast-Cancer Incidence in 2003 in the United StatesNew England Journal of Medicine, 2007
- Effects of Conjugated Equine Estrogens on Breast Cancer and Mammography Screening in Postmenopausal Women With HysterectomyJAMA, 2006
- Breast cancer and hormone-replacement therapy in the Million Women StudyThe Lancet, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002